Analyst Consensus ?
ConsensusBuy22 ratings
Bullish1881.8%
Neutral418.2%
Bearish00.0%
Axon Enterprise, Inc. · AXON · FY2024 Q2 · Calendar Q3 2024
Axon posts record Q2 as AI, cloud and international demand accelerate
The current analysis supports a constructive but conditional thesis for Axon: resilient demand, expanding cloud and software adoption, AI cross-sell potential and international growth can support continued expansion, while monetization, procurement cycles, regulation and budget sensitivity remain important tests.
Reported After market closeNASDAQIndustrials
$33.32B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.20
Consensus $1.02
EPS surprise
+17.6%
Reported versus consensus
Reported revenue
$504.1M
Consensus $478.4M
Revenue surprise
+5.4%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+18.4%
Event window
SPY move
-0.7%
Same window
Abnormal move
+19.1%
Stock minus SPY
Volume
6.0×
Versus trailing sessions
Subsequent drift
+1.6%
Up to 20 sessions
AXONSPY benchmark
Ask FN2 about AXON FY2024 Q2
Transcript, numbers and history already loaded
Why did AXON rise 18.4% after beating EPS estimates in FY2024 Q2?What changed in AXON's guidance and outlook in FY2024 Q2?Give me the bull and bear case for AXON after FY2024 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, Axon moved from a planned Dedrone acquisition and early Draft One adoption toward a broader platform narrative: record Q2 revenue and bookings, software and cloud services at 39% of revenue, 47% year-over-year Cloud growth, faster international bookings and a larger Fusus role. Management also raised full-year revenue guidance and continued to emphasize capacity expansion.
Guidance delta
Management raised full-year revenue guidance to $2.0-$2.05 billion, versus $1.94-$1.99 billion in the prior-quarter analysis.
Key takeaways
- Axon reported record Q2 revenue and bookings, with revenue surpassing $500 million for the first time.
- Draft One is gaining traction and creating cross-sell opportunities, while its monetization path remains an area to monitor.
- Software and cloud services represented 39% of revenue; the Cloud segment grew 47% year over year.
- International bookings grew 100% year to date, with several large contracts signed outside the United States.
- Management highlighted Fusus, drones and the sensor ecosystem as additional growth avenues.
Management priorities
- Announce new AI and productivity product updates at the IACP conference in October.
- Complete and integrate the Dedrone acquisition.
- Scale Fusus as the core platform for dispatch and mapping across public-safety agencies.
- Expand drone partnerships and Drone as First Responder offerings.
- Invest in additional manufacturing capacity for TASER devices and cartridges.
Follow AXON with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$413.35Current
$300Low
$663.7Average
$900High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Buy | Buy | Maintain | Sep 3, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Needham | Buy | Buy | Maintain | Jul 6, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jun 25, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 7, 2026 |
| TD Cowen | Buy | Buy | Maintain | Apr 8, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 8, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Feb 25, 2026 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Sep 29, 2025 |
| B of A Securities | Buy | Buy | Maintain | Aug 6, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Aug 5, 2025 |
| Northland Capital Markets | Outperform | Outperform | Maintain | Aug 5, 2025 |
| Craig-Hallum | Buy | Hold | Upgrade | Aug 5, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Feb 26, 2025 |
| Baird | Outperform | Outperform | Maintain | Dec 6, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 10, 2023 |
| Imperial Capital | In Line | In Line | Maintain | May 18, 2020 |
| Ladenburg Thalmann | Neutral | Buy | Downgrade | Oct 15, 2018 |
| CL King | Neutral | Buy | Downgrade | Mar 16, 2018 |
Named analyst price targets
Upside is calculated against the persisted current price $413.35. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Argus Research | Analyst unavailable | $600 | $506.98 | +45.2% | Sep 3, 2026 |
| Morgan Stanley | Meta Marshall | $640 | $528.41 | +54.8% | Aug 6, 2026 |
| Goldman Sachs | Analyst unavailable | $715 | $561.47 | +73.0% | Aug 6, 2026 |
| Piper Sandler | Analyst unavailable | $732 | $551.4 | +77.1% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $688 | $609.49 | +66.4% | Aug 6, 2026 |
| Piper Sandler | Analyst unavailable | $724 | $565.8 | +75.2% | Jul 13, 2026 |
| Needham | Analyst unavailable | $750 | $597.04 | +81.4% | Jul 6, 2026 |
| Piper Sandler | James Fish | $674 | $457.33 | +63.1% | Jun 15, 2026 |
| Barclays | Tim Long | $523 | $426.89 | +26.5% | May 8, 2026 |
| Morgan Stanley | Analyst unavailable | $600 | $433.82 | +45.2% | May 7, 2026 |
| Goldman Sachs | Analyst unavailable | $535 | $434.5 | +29.4% | May 7, 2026 |
| UBS | Analyst unavailable | $440 | $416.57 | +6.4% | May 7, 2026 |
| Morgan Stanley | Analyst unavailable | $675 | $391.53 | +63.3% | Apr 8, 2026 |
| Goldman Sachs | Analyst unavailable | $625 | $391.53 | +51.2% | Apr 8, 2026 |
| Robert W. Baird | Analyst unavailable | $800 | $523.63 | +93.5% | Feb 25, 2026 |
| Craig-Hallum | Jeremy Hamblin | $820 | $543.47 | +98.4% | Feb 25, 2026 |
| RBC Capital | David Paige | $735 | $543.24 | +77.8% | Feb 25, 2026 |
| Piper Sandler | James Fish | $690 | $548.22 | +66.9% | Feb 25, 2026 |
| Northcoast Research | Keith Housum | $742 | $591.16 | +79.5% | Jan 6, 2026 |
| Morgan Stanley | Meta Marshall | $713 | $555.06 | +72.5% | Dec 17, 2025 |
| RBC Capital | Analyst unavailable | $860 | $554.37 | +108.1% | Nov 17, 2025 |
| Piper Sandler | James Fish | $753 | $622.38 | +82.2% | Nov 5, 2025 |
| Raymond James | Analyst unavailable | $855 | $867.12 | +106.8% | Aug 5, 2025 |
| Northland Securities | Michael Latimore | $800 | $867.12 | +93.5% | Aug 5, 2025 |
| Needham | Joshua Reilly | $870 | $867.12 | +110.5% | Aug 5, 2025 |
| UBS | Analyst unavailable | $840 | $867.12 | +103.2% | Aug 5, 2025 |
| Craig-Hallum | Analyst unavailable | $900 | $867.12 | +117.7% | Aug 5, 2025 |
| Morgan Stanley | Meta Marshall | $885 | $729.62 | +114.1% | Jul 11, 2025 |
| Barclays | Analyst unavailable | $726 | $506.96 | +75.6% | Feb 27, 2025 |
| Morgan Stanley | Meta Marshall | $700 | $636.39 | +69.3% | Dec 3, 2024 |
| Needham | Joshua Reilly | $525 | $443.98 | +27.0% | Oct 22, 2024 |
| Goldman Sachs | Michael Ng | $441 | $443.98 | +6.7% | Oct 22, 2024 |
| Robert W. Baird | William Power | $400 | $364.39 | -3.2% | Sep 10, 2024 |
| Craig-Hallum | Jeremy Hamblin | $370 | $315.35 | -10.5% | May 7, 2024 |
| Needham | Joshua Reilly | $400 | $311.27 | -3.2% | Apr 10, 2024 |
| Argus Research | John Staszak | $380 | $306.78 | -8.1% | Mar 13, 2024 |
| Credit Suisse | Sami Badri | $300 | $225.13 | -27.4% | Apr 11, 2023 |
| Morgan Stanley | Analyst unavailable | $155 | $168.59 | -62.5% | Dec 13, 2022 |
Track every rating change on AXON the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAxon Enterprise, Inc., founded in 1993 and headquartered in Scottsdale, Arizona, was previously known as TASER International, Inc. until its rebranding in April 2017. The company specializes in the development, production, and sale of conducted energy devices (CEDs) marketed under its well-known TASER brand, catering to both domestic and international clients. Axon's operations are divided into two primary segments: TASER, and Software and Sensors. In addition to its signature TASER devices, such as the TASER 7, X26P, X2, and consumer models, along with their corresponding cartridges, Axon offers an extensive portfolio of hardware and cloud-based software.…
Historical context
All AXON earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| DAL Delta Air Lines, Inc. | FY2026 Q3 · Calendar Q4 2026 | -2.8% | +0.0% | Delta reports strong Q3 demand while costs and capacity remain key watchpoints |
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the AXON recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
- Polygon adjusted daily market bars · 2026-10-14T02:10:41.737999+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-14T02:10:41.735261+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-14. For educational purposes only; not investment advice.